FOXA1 and breast carcinoma: The importance of this connection between JAM-A expression and HER2-positivity is reinforced by the fact that HER2-negative patients and the overall breast cancer patient population showed the opposite correlation, namely more favorable survival statistics in those with high coincident JAM-A, HER2 and FOXA1 expression.